Hypothesis

In aged skeletal muscle, chronic low‑level Ca²⁺ leak from RyR1 maintains calcineurin activity, which keeps NFATc4 constitutively nuclear. Nuclear NFATc4 recruits HDAC‑containing complexes to the miR-23a promoter, leading to its epigenetic silencing. Loss of miR-23a derepresses the atrophy genes atrogin-1 (MAFbx) and MuRF1, triggering fiber‑type‑selective sarcopenia.

Mechanistic Model

• Ca²⁺ dysregulation: Aging increases diastolic Ca²⁺ leak through ryanodine receptor 1 (RyR1), producing a persistent sub‑threshold calcineurin signal [3].
• NFATc4 specificity: Unlike activity‑dependent NFATc1, NFATc4 is already nuclear in resting fibers [2]; sustained calcineurin activity prevents its export and promotes interaction with co‑repressors (e.g., HDAC1/2, Sin3A).
• Epigenetic repression: NFATc4‑HDAC complexes deacetylate histones at the miR-23a locus, establishing a repressive chromatin state that diminishes pri‑miR-23a transcription.
• miR-23a loss: Reduced miR-23a relieves inhibition of atrogin-1 and MuRF1 mRNAs, accelerating ubiquitin‑proteasome–mediated protein breakdown.
• Fiber‑type bias: Slow‑twitch fibers, which rely on NFATc1 for maintenance, are less affected, whereas fast‑twitch fibers exhibit greater NFATc4‑driven atrophy, consistent with selective type‑II fiber loss in sarcopenia.

Testable Predictions

1. Correlation: In muscle from aged (≥24 mo) mice, nuclear NFATc4 levels will inversely correlate with miR-23a expression and positively correlate with atrogin-1/MuRF1 mRNA across individual fibers.
2. Causality: Genetic knockdown of NFATc4 (e.g., AAV‑shNFATc4) in aged muscle will restore miR-23a levels, reduce atrogene expression, and attenuate atrophy despite unchanged RyR1 leak.
3. Pharmacological rescue: Acute inhibition of calcineurin with FK506 in aged mice will increase miR-23a transcription and decrease nuclear NFATc4 occupancy at its promoter (ChIP‑qPCR).
4. Epigenetic mark: ChIP‑seq for H3K27ac will show reduced acetylation at the miR-23a promoter in aged muscle, reversible by NFATc4 knockdown.

Experimental Approach

• Animal models: Use young (3 mo) and aged (24 mo) C57BL/6 mice; include a RyR1‑stabilizing arm (dantrolene low dose) to dissect Ca²⁺ contribution.
• Readouts:
  • Immunofluorescence for NFATc4 nuclear/cytoplasmic ratio (fiber‑type specific).
  • Small‑RNA qPCR for miR-23a.
  • RT‑qPCR and Western blot for atrogin-1, MuRF1, and downstream ubiquitination.
  • ChIP‑qPCR for NFATc4, HDAC1, and H3K27ac at the miR-23a promoter.
  • Muscle cross‑sectional area and fiber‑type profiling (MyHC isoforms).
• Interventions: AAV9‑mediated shRNA against NFATc4 or scrambled control; systemic FK506 (1 mg/kg/day, 2 weeks).
• Statistical plan: Power analysis targeting 80 % power to detect 30 % change in miR-23a (α = 0.05). Two‑way ANOVA (age × treatment) with post‑hoc Tukey.

If nuclear NFATc4 directly suppresses miR-23a to drive atrophy, rescuing miR-23a should blunt sarcopenic fiber loss even in the presence of age‑related Ca²⁺ leak, providing a mechanistic link between calcineurin/NFAT signaling, microRNA networks, and muscle aging.